newsfilter
← Latest News
GlobeNewswire·

Chiasma To Report Fourth Quarter and Full Year 2019 Financial Results On March 16, 2020

NEEDHAM, Mass., March 09, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic...